logo
Plus   Neg
Share
Email

Regeneron, Sanofi: European Commission Approves New Indication For Dupixent

Regeneron Pharmaceuticals, Inc. (REGN) and Sanofi announced the European Commission has approved a new indication for Dupixent in chronic rhinosinusitis with nasal polyposis. Dupixent is now approved in the EU for three type 2 inflammatory diseases: severe chronic rhinosinusitis with nasal polyposis, severe asthma and moderate-to-severe atopic dermatitis.

Dupixent is a fully-human monoclonal antibody that inhibits the signaling of the interleukin-4 and interleukin-13 proteins. Dupilumab is being jointly developed by Regeneron and Sanofi under a global collaboration agreement. Dupixent was invented using Regeneron's VelocImmune technology, which uses a genetically-humanized mouse to produce optimized fully-human antibodies.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Walmart Canada has apologized after a Christmas sweater featuring Santa Claus and apparently cocaine was posted for sale on the company's Canadian website. The retail giant pulled the controversial sweater from its website following a backlash on social media. However, the sweater was not available on Walmart's U.S. website. Ford Motor Co. is recalling around 262 thousand F-Series heavy-duty pickups in the U.S. and Canada citing problem with the electric tailgates that may open unintentionally. The recall involves F-250, F-350 and F-450 Super Duty trucks from the 2017 through 2019 model years. Of these, 231,664 vehicles are in the U.S., while 29,953 are in Canada. Sony's 'MLB The Show' video game series will be available on additional console platforms beyond PlayStation as early as 2021. Currently, the game series is exclusive to PlayStation. 'MLB The Show' is the MLB's officially licensed simulation baseball video game series. San Diego Studio has been creating the officially licensed baseball video games enjoyed by fans for more than 20 years.
Follow RTT
>